eastern medicine
Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
– 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic – Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced a year-end review of accomplishments during 2018 and insight into plans […]
Creso Pharma Brings Together Cannabis Experts Across Several Verticals
The due diligence process looks very different for small-cap versus large-cap stocks. When analyzing large-cap companies, investors pay closest attention to financial statements and valuation ratios to extrapolate growth rates and apply multiples. Small-cap stocks tend to be earlier stage companies without an established earnings track record, which means that investors must consider the management […]
NanoSphere Forms Strategic Partnership to Launch Evolve Products in Mexico
VANCOUVER, British Columbia Agreement will bring the patented NanoSphere Delivery System™ to an emerging $5 billion cannabis market NanoSphere Health Sciences Inc. (CSE:NSHS) (OTC:NSHSF) (“NanoSphere” or “the Company”), the biotechnology leader behind the patented NanoSphere Delivery System™, is pleased to announce the Company has signed a Letter of Intent forming a partnership with Abba Import […]
Canntab Nears Commercialization with Innovative Cannabis Tablets
The global cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a blistering 34.6 percent compound annual growth rate. With medical and adult-use legalization across a growing number of countries, there’s an enormous opportunity for innovative companies to become established market leaders and patients to access new life-changing […]
VANCOUVER, BRITISH COLUMBIA, and SEATTLE, WASHINGTON, November 28, 2018 – Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the strengthening of its leadership team with the appointments of seasoned executives in therapeutic and business development. These include Kevin M. Egan, MBA, Vice President Business Development, Thomas Deckwerth, […]
How Dual Listings Are Helping Cannabis Companies Access Capital
The cannabis industry is projected to reach C$22.6 billion by 2026, according to Cowen & Co., driven by the legalization of adult-use cannabis earlier this year. While Canadian investors have been voracious buyers, many companies have expanded their efforts to reach United States and European investors through dual-listings. These dual-listings offer the ability to increase […]
MedMen Expanding Across the US Legal Cannabis Markets
The recent elections brought the total number of states allowing some form of legalized cannabis to 33, with Michigan expanding its medical program to full adult use legalization and both Utah and Missouri voting for regulated medical programs. The legal U.S. cannabis market is steadily growing, making it the largest legal cannabis market in the […]
48North Cannabis Corp. Acquires Good & Green for Next Generation Cannabis Products
In late October of this 2018, 48North Cannabis Corp. (TSX-V: NRTH) entered into a binding letter agreement to acquire all issued and outstanding common shares of privately-held Good & Green, a socially-responsible, organic cannabis brand. Combined with a variety of vertically integrated partnerships, investors are keen to watch the movement of 48North as it […]
Early Cannabis Legalization Struggles Could Yield Opportunities
Canada became the first major economy to legalize adult-use cannabis on October 17th, but cannabis stocks quickly gave up their gains leading up to the historic day. In addition to traders “selling the news” and locking in their gains, supply shortages, distribution issues, and quality concerns contributed to a major pullback in the sector. The […]
The Crucial Role of Genetics in the Future of the Cannabis Industry
The history of the legal cannabis industry is fairly short, a work in progress. The legal market is only beginning to leave behind its black market origins, and the prohibition on scientific research around the plant is being lifted. One fact that has recently come to light is that a particular strain of cannabis can […]
VANCOUVER, British Columbia and SEATTLE, Nov. 05, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the peer reviewed publication and upcoming presentation of their recently licensed cannabinoid-derived drug program for glioblastoma. Dr. Stella and colleagues are publishing their work today in the European […]
High Hampton Signs LOI to Acquire California Extracts Manufacturer
The cannabis industry is projected to reach $75 billion by 2030, according to Cowen & Co., driven by the legalization of medical and recreational cannabis across a growing number of states. According to Arcview Market Research and BDS Analytics, a large portion of that growth will come from California’s newly legalized recreational market, which the […]
Leading-edge cannabis wellness company brings new cannabis-infused products to California CALGARY, Nov. 2, 2018 /CNW/ – Gabriella’s Kitchen Inc. (“GABY” or the “Company“) (CSE: GABY), an innovative and leading-edge cannabis wellness company, is pleased to announce that its alto™ brand of cannabis infused products (“Infused Products”) have launched in Northern California. GABY offers a variety […]
48North Cannabis Corp. Announces Transformational Acquisition and $10MM Private Placement
TORONTO, Oct. 30, 2018 /CNW/ – 48North Cannabis Corp. (“48North” or the “Company”) (TSXV:NRTH) and 2599708 Ontario Inc. (“Good & Green”) have entered into a letter agreement that became binding on October 29, 2018, whereby 48North will acquire all of the issued and outstanding common shares of privately-held Good & Green in an all-share transaction valued […]
Bloomberg Interviews FSD Pharma for Cannabis Shortage Feature
Canada may have legalized adult-use cannabis on October 17, but that doesn’t mean consumers are able to purchase the drug. According to Bloomberg, there are widespread shortages across the country, despite an ample supply of licensed producers awaiting approval from Health Canada. Many of these licensed producers have been waiting a year or more after […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Resolve Digital Health Inc. committed to establishing a standard of care missing from the medical cannabis industry until now.
Innovium is a global beverage and foods brands platform that builds on consumer market trends and takes them to scale.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
